Alliance Pharmaceutical Corp. Resources | BNET
On last.fm: Listen to Up and Coming Artist

BNET Industries

Alliance Pharmaceutical Corp. (ALLP) is in the Pharma Industry

Revenue
Jun 30 2007
$573.0K
Profit
Jun 30 2007
($4.0M)
Market Cap
Jul 22 2008
$1.2M

Latest News and Analysis

  • Alliance Pharmaceutical Corp. Announces Approval of Proposed Actions at Annual Shareholders Meeting

    LA JOLLA, Calif., June 2 /PRNewswire-FirstCall/ -- Alliance Pharmaceutical Corp. (BULLETIN BOARD: ALLP) announced today the results of the vote of its shareholders on the two proposals put to the shareholders at its Annual Meeting of Shareholders held Friday, May 30, 2008. The first proposal...

    Articles 2008-06-02

  • JRCC, NFLX, TASR, UTSI, AEGG, ALLP Have Also Been Removed From Naked Short List Today.

    M2 PRESSWIRE-4 January 2008-BUYINS.NET: JRCC, NFLX, TASR, UTSI, AEGG, ALLP Have Also Been Removed From Naked Short List TodayC1994-2008 M2 COMMUNICATIONS LTD RDATE:04012008 BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and...

    Articles 2008-01-04

  • Covad Honored with California Innovation Award

    Wireless News04-27-2007Covad Honored with California Innovation AwardWIRELESS NEWS-April 27, 2007-Covad Honored with California Innovation Award C2007 10Meters - http://www.10meters.com Covad Communications Group, a national provider of integrated voice and data communications, announced that it has been recognized as one of 15 Innovation All-Stars by California Tech 100 Partners and...

    Articles 2007-04-27

  • Covad Recognized with California Innovation Award

    Governor Schwarzenegger's Commission for Jobs and Economic Growth Honors California's Top Businesses with Innovation Awards SAN JOSE, Calif. -- Covad Communications Group, Inc. (AMEX: DVW), a national provider of integrated voice and data communications, announced today that it has been recognized as one of 15 Innovation All-Stars by...

    Articles 2007-04-26

  • Partner Draws Attention: Sector Evaluated.

    M2 PRESSWIRE-28 March 2007-Pinnacle Digest: Partner Draws Attention: Sector EvaluatedC1994-2007 M2 COMMUNICATIONS LTD RDATE:28032007 To read this article in its entirety, visit www.pinnacledigest.com. Alliance Pharmaceutical Corp. (OTC:BB: ALLP) experienced a decrease in share value Tuesday dropping 3.85 along with...

    Articles 2007-03-28

  • Incorporated: 1983
  • CEO: Mr. Duane J. Roth
  • Employees: 1

Alliance Pharmaceutical is a pharmaceutical research and development company that is focused on developing its main product, OXYGENT™, (perfluorochemical (PFC) emulsion) an intravascular oxygen carrier designed to augment oxygen delivery in surgical patients. Co. has developed certain proprietary technologies for medical applications based on the use of biochemically inert perfluorooctyl bromide, a brominated PFC that has a high solubility for respiratory gases. When formulated into an emulsion, OXYGENT can be used to transport respiratory gases throughout the body. It is sterile, compatible with all blood types and is expected to have a "shelf life" of approximately two years.

Key Competitors

Alliance Pharmaceutical Corp. Company Info

Board of Directors

Mr. Duane J. Roth

Chairman

Dr. Pedro Cuatrecasas

Mr. Carroll O. Johnson

Mr. Stephen M. McGrath

Dr. Jean G. Riess Ph.D.

Mr. Theodore D. Roth

Contact Information

7590 Fay Avenue

Suite 402

La Jolla, CA

http://www.allp.com

858 410-5200

NAICS Code

Pharmaceutical Preparation Manufacturing: 325412